-
AR-42
- names:
AR-42
- CAS号:
935881-37-1
MDL Number: - MF(分子式): C18H20N2O3 MW(分子量): 312.36
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM001351-10mg | 10mg | 97.18% | ¥ 2685.15 | ¥ 2685.15 | 2-3天 | ¥ 0.00 | ||
| YZM001351-5mg | 5mg | 97.18% | ¥ 1436.50 | ¥ 1436.50 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | AR-42 |
| CAS号 | 935881-37-1 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C18H20N2O3 |
| 分子量 Molecular Weight | 312.36 |
| 溶解度Solubility | 生物体外In Vitro:Ethanol : 50 mg/mL(160.07 mM;Need ultrasonic) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | AR2 (HDAC2) is a potent, orally bioavailable panDACinhibitor (IC50=16 nM). AR2 induces growth inhibition, cellycle arrest,apoptosis, and activation of caspases/7. AR2 promotes hyperacetylation of H3, H4, and alphaubulin, and upegulation of p21. AR2 (HDAC2) shows cytotoxicity against various human cancer cell lines. |
| Application1 | |
| Application2 | |
| Application3 |
AR-42 (HDAC-42) 是一种有效的口服生物有效的泛HDAC抑制剂 (IC50=16 nM)。AR-42 (HDAC-42) 诱导生长抑制、细胞周期阻滞、凋亡和 caspases-3/7 活化。AR-42 (HDAC-42) 促进 H3、H4 和 α-微管蛋白的高乙酰化,并上调 p21。AR-42 (HDAC-42) 对多种人肿瘤细胞具有细胞毒性。AR-42 (HDAC-42) is a potent, orally bioavailable pan-HDACinhibitor (IC50=16 nM). AR-42 induces growth inhibition, cell-cycle arrest,apoptosis, and activation of caspases-3/7. AR-42 promotes hyperacetylation of H3, H4, and alpha-tubulin, and up-regulation of p21. AR-42 (HDAC-42) shows cytotoxicity against various human cancer cell lines.
【1】.Lu YS, Chou CH, Tzen KY, Gao M, ChLu YS, et al. Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e181-9.eng AL, Kulp SK, Cheng JC.Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma.Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e181-9. Epub 2012 Feb 28.
【2】.Lu Q, et al. Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. J Med Chem. 2005 Aug 25;48(17):5530-5.
【3】.Lin TY, et al. AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit. Blood. 2010 May 27;115(21):4217-25.
【4】.Zhang M, et al. AR-42 induces apoptosis in human hepatocellular carcinoma cells via HDAC5 inhibition. Oncotarget. 2016 Apr 19;7(16):22285-94.
【2】.Lu Q, et al. Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. J Med Chem. 2005 Aug 25;48(17):5530-5.
【3】.Lin TY, et al. AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit. Blood. 2010 May 27;115(21):4217-25.
【4】.Zhang M, et al. AR-42 induces apoptosis in human hepatocellular carcinoma cells via HDAC5 inhibition. Oncotarget. 2016 Apr 19;7(16):22285-94.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


